The Unitary Enterprise "Pilot Production of the Institute of Bioorganic Chemistry" offers consumers Rapid test for the detection of IgM and IgG antibodies to the SARS-CoV-2 coronavirus in human blood, serum, and plasma using immunochromatographic analysis - Rapid test SARS CoV-2IgM/IgG under a manufacturing agreement and is looking for partners to conclude a distribution services agreement.

Rapid tests for the qualitative and rapid detection of IgM and IgG antibodies to the SARS-CoV-2 virus using immunochromatographic assays (ICAs) are widely used to diagnose COVID-19, assess the immune response, and detect past infections. These tests are used to analyze blood, serum, or plasma samples.

Major global manufacturers of rapid tests for the detection of IgM and IgG antibodies to SARS-CoV-2:

1. Abbott Laboratories (USA)
- Features: The company offers tests such as the Panbio™ COVID-19 IgG/IgM Rapid Test, which provide rapid and accurate antibody detection.
2. Roche Diagnostics (Switzerland)
- Features: Manufacturer of the Elecsys® Anti-SARS-CoV-2 tests, which are suitable for the qualitative detection of antibodies in serum and plasma.
3. SD Biosensor (South Korea)
- Features: Manufacturer of the Standard™ Q COVID-19 IgM/IgG Duo Test, which is widely used for diagnostics and immune monitoring.
4. Healgen Scientific (USA)
- Features: Manufacturer of the COVID-19 IgG/IgM Rapid Test Cassette, which provides results within 10-15 minutes.
5. Innovita Biological Technology (China)
- Features: The company offers the Innovita 2019-nCoV Ab Test, which is widely used in healthcare settings.

A rapid test manufactured by the Self-Supporting Pilot Production Enterprise of the Institute of Bioorganic Chemistry for the high-quality, rapid (15 minutes) detection of IgM and IgG antibodies of the SARS-CoV-2 virus in human blood, serum, and plasma using immunochromatographic analysis (SARS-CoV-2-IgM/IgG Rapid Test).

The rapid test is intended for in vitro diagnostics. The rapid test has a shelf life of 24 months. Store at a temperature of 2-30°C.

Information about the SARS-CoV-2 IgM/IgG Rapid Test, including the Test Protocol, Instructions, Instructions for Pharmacies, and a flyer, is available on the Company's official website here. (in Russian)

For sale in pharmacies:
- 1 test cassette, 1 polymer Pasteur pipette, individually packaged with desiccant, ready to use;
- 1 tube of buffer solution, 90 µl, ready to use;
- 1 alcohol swab, ready to use;
- 1 lancing device (scarifier, lancet), ready to use;
- instructions for use.

The Unitary Enterprise "Pilot Production of the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus" was founded in 1986 as a specialized facility for the production of radioimmunoassay kits for the diagnosis of various human diseases. Today, it is a modern biotechnology enterprise with highly qualified personnel and a state-of-the-art production and technical infrastructure, enabling it to carry out complex technological processes and produce high-quality products.

The Unitary Enterprise "Pilot Production of the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus" produces SARS-CoV-2-IgM/IgG rapid tests for the rapid detection of IgM and IgG antibodies to the SARS-CoV-2 coronavirus, which causes COVID-19.

Radioimmunoassay kits are the main type of diagnostic products manufactured. They are designed to diagnose thyroid diseases, assess the reproductive system and endocrine-metabolic processes, and identify tumor markers. The kits are equipped with solid-phase immunosorbents based on monoclonal antibodies and stabilized, ready-to-use liquid forms of standards and radioactively labeled preparations. In terms of analytical parameters and performance characteristics, these kits match the best foreign analogues.

The company, in collaboration with the Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus, develops and manufactures enzyme immunoassay kits for hormonal (for determining thyroid, steroid, and pituitary hormones) and oncology profiles, as well as kits based on lanthanide immunofluorimetric analysis for prenatal and neonatal diagnostics.

The infectious disease-specific enzyme immunoassay kits manufactured by the company through industrial cooperation are intended for the diagnosis of syphilis, viral hepatitis B and C, TORCH infections, AIDS, and coronavirus.

Official website of the Enterprise "Pilot production of the Institute of Bioorganic Chemistry."

The Enterprise has implemented a quality management system for the production of in vitro diagnostic reagent kits. In 2012, the company's quality management system was certified for compliance with the requirements of STB ISO 9001-2009 (Certificate of Conformity STB No. BY/112 05 01.002 02704). In 2017, the company's quality management system was certified for compliance with the requirements of the international standard EN ISO 13485:2012 (Certificate No. 9124.IBCN).

Consumers interested in purchasing the SARS-CoV-2 Rapid Test for the Detection of IgM and IgG Antibodies in Blood, Serum, and Plasma Using the Immunochromatographic Assay (SARS-CoV-2IgM/IgG Rapid Test) under a manufacturing agreement.

Partners interested in purchasing the SARS-CoV-2 Rapid Test for the Detection of IgM and IgG Antibodies in Blood, Serum, and Plasma Using the Immunochromatographic Assay (SARS-CoV-2IgM/IgG Rapid Test) under a distribution services agreement.